NEKTAR THERAPEUTICS Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for May 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 83.39 | 3,576 | 298,203 | 65,281 | 68.9 K to 65.3 K (-5.19 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 83.39 | 12,791 | 1,066,641 | 224,356 | 237.1 K to 224.4 K (-5.39 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 83.39 | 4,917 | 410,029 | 162,596 | 167.5 K to 162.6 K (-2.94 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 83.39 | 4,941 | 412,030 | 94,798 | 99.7 K to 94.8 K (-4.95 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 83.39 | 4,060 | 338,563 | 76,201 | 80.3 K to 76.2 K (-5.06 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 83.39 | 3,435 | 286,445 | 63,959 | 67.4 K to 64 K (-5.10 %) |
| May 04 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 5.14 | 15,000 | 77,100 | 0 | |
| May 04 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 14.26 | 10,000 | 142,600 | 10,000 | |
| May 04 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 82.81 | 15,000 | 1,242,150 | 274,223 | 289.2 K to 274.2 K (-5.19 %) |
| May 04 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 5.14 | 15,000 | 77,100 | 289,223 | 274.2 K to 289.2 K (+5.47 %) |
| May 04 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 82.79 | 10,000 | 827,900 | 274,223 | 284.2 K to 274.2 K (-3.52 %) |
| May 04 2018 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 14.26 | 10,000 | 142,600 | 284,223 | 274.2 K to 284.2 K (+3.65 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 10.69 | 30,000 | 320,700 | 0 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 10.69 | 30,000 | 320,700 | 30,000 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 10.69 | 30,000 | 320,700 | 60,000 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 82.86 | 30,000 | 2,485,800 | 99,739 | 129.7 K to 99.7 K (-23.12 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 10.69 | 30,000 | 320,700 | 129,739 | 99.7 K to 129.7 K (+30.08 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 85.63 | 30,000 | 2,568,900 | 99,739 | 129.7 K to 99.7 K (-23.12 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 10.69 | 30,000 | 320,700 | 129,739 | 99.7 K to 129.7 K (+30.08 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 83.65 | 30,000 | 2,509,500 | 99,739 | 129.7 K to 99.7 K (-23.12 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 10.69 | 30,000 | 320,700 | 129,739 | 99.7 K to 129.7 K (+30.08 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 10.69 | 43,333 | 463,230 | 170,000 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 10.69 | 43,333 | 463,230 | 213,333 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 10.69 | 43,334 | 463,240 | 256,666 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 82.86 | 43,333 | 3,590,572 | 237,147 | 280.5 K to 237.1 K (-15.45 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 10.69 | 43,333 | 463,230 | 280,480 | 237.1 K to 280.5 K (+18.27 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 85.63 | 43,333 | 3,710,605 | 237,147 | 280.5 K to 237.1 K (-15.45 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 10.69 | 43,333 | 463,230 | 280,480 | 237.1 K to 280.5 K (+18.27 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 83.65 | 43,334 | 3,624,889 | 237,147 | 280.5 K to 237.1 K (-15.45 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 10.69 | 43,334 | 463,240 | 280,481 | 237.1 K to 280.5 K (+18.27 %) |